MedTrace Logo

Novel Lung Functional Imaging for Personalized Radiotherapy

NCT02308709 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 34

Last updated 2022-11-10

Study results available
· View outcomes & findings →

Summary

The primary objective of this study is to assess the safety and feasibility of personalized radiotherapy with four-dimensional (4D) computed tomography (CT)-based pulmonary ventilation imaging, which selectively avoids irradiating highly-functional lung regions.

Conditions

Interventions

RADIATION

Ventilation image-guided radiotherapy

Patient's treatment plan will be created and optimized to minimize the dose to highly-functional lung regions

Sponsors & Collaborators

  • University of California, Davis

    lead OTHER

Principal Investigators

  • Tokihiro Yamamoto, Ph.D. · University of California, Davis

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-15
Primary Completion
2020-11-19
Completion
2021-11-19

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02308709 on ClinicalTrials.gov